Jean Coutu has taken steps to prepare its customers and pharmacists for the expanded services the pharmacy can now provide with the implementation of Bill 41, which amends the Pharmacy Act.
Americans feel healthier under the Affordable Care Act, according to a study published on Tuesday in the Journal of the American Medical Association.
Voters from all political parties support sunshine legislation that would make promote transparency in generic prescription drug payments by pharmacy benefit manager corporations, according to a national survey from the National Community Pharmacists Association released Tuesday.
The National Association of Chain Stores commented this week on the Centers for Medicare and Medicaid Services’ proposed regulations guiding the use of managed care in Medicaid and in the Children’s Health Insurance Program.
The Council for Responsible Nutrition will host a conversation with key regulators of the dietary supplement industry at annual meeting.
A GAO report released Monday suggests that the Drug Enforcement Agency should take steps to improve communications with pharmacists, manufacturers.
The GpHA and Biosimilars Council have published their objections to the Trans-Pacific Partnership trade agreement to the pages of the New York Times.
The Israeli Health Ministry approved on Monday a decision to allow patients licensed to receive medical marijuana from a pharmacy with authorization from a medical expert, according to theJerusalem Post.
The FDA has approved Daklinza (daclatasvir), in combination with sofosbuvir, in treatment for chronic hepatitis C virus genotype 3 infections.
The Food and Drug Administration announced Friday that it approved Technivie (ombitasvir, paritaprevir and ritonavir) for use in combination with ribavirin for the treatment of hepatitis C virus (HCV) genotype 4 infections in patients without scarring and cirrhosis.